Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands.
cyclostreptin
microtubules
multidrug resistance
taxanes
tubulin
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
20 Mar 2019
20 Mar 2019
Historique:
received:
28
02
2019
revised:
14
03
2019
accepted:
15
03
2019
entrez:
23
3
2019
pubmed:
23
3
2019
medline:
13
7
2019
Statut:
epublish
Résumé
It has been proposed that one of the mechanisms of taxane-site ligand-mediated tubulin activation is modulation of the structure of a switch element (the M-loop) from a disordered form in dimeric tubulin to a folded helical structure in microtubules. Here, we used covalent taxane-site ligands, including cyclostreptin, to gain further insight into this mechanism. The crystal structure of cyclostreptin-bound tubulin reveals covalent binding to βHis229, but no stabilization of the M-loop. The capacity of cyclostreptin to induce microtubule assembly compared to other covalent taxane-site agents demonstrates that the induction of tubulin assembly is not strictly dependent on M-loop stabilization. We further demonstrate that most covalent taxane-site ligands are able to partially overcome drug resistance mediated by βIII-tubulin (βIII) overexpression in HeLa cells, and compare their activities to pironetin, an interfacial covalent inhibitor of tubulin assembly that displays invariant growth inhibition in these cells. Our findings suggest a relationship between a diminished interaction of taxane-site ligands with βIII-tubulin and βIII tubulin-mediated drug resistance. This supports the idea that overexpression of βIII increases microtubule dynamicity by counteracting the enhanced microtubule stability promoted by covalent taxane-site binding ligands.
Identifiants
pubmed: 30897704
pii: ijms20061392
doi: 10.3390/ijms20061392
pmc: PMC6471726
pii:
doi:
Substances chimiques
FR 182877
0
Polycyclic Compounds
0
Taxoids
0
Tubulin
0
Edetic Acid
9G34HU7RV0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : BFU2016-75319-R
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : RYC-2011-07900
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 31003A_166608
Organisme : National Institutes of Health
ID : CA121138
Organisme : European Cooperation in Science and Technology
ID : CM1407
Références
Br J Cancer. 1999 Jun;80(7):1020-5
pubmed: 10362110
J Biol Chem. 2000 Aug 25;275(34):26265-76
pubmed: 10818101
Curr Opin Oncol. 2000 Sep;12(5):450-8
pubmed: 10975553
J Biol Chem. 2003 Mar 7;278(10):8407-19
pubmed: 12496245
J Am Chem Soc. 2003 May 7;125(18):5393-407
pubmed: 12720453
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6394-7
pubmed: 12740436
Cell Motil Cytoskeleton. 2003 Sep;56(1):45-56
pubmed: 12905530
Nature. 2004 Mar 11;428(6979):198-202
pubmed: 15014504
Chem Biol. 2004 Feb;11(2):225-36
pubmed: 15123284
J Biol Chem. 2005 Feb 4;280(5):3928-37
pubmed: 15550392
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Clin Cancer Res. 2005 Jan 1;11(1):298-305
pubmed: 15671559
J Biol Chem. 2005 Apr 1;280(13):12902-7
pubmed: 15695826
Biochemistry. 2005 Aug 30;44(34):11525-38
pubmed: 16114889
Chem Biol. 2005 Dec;12(12):1269-79
pubmed: 16356844
Nat Chem Biol. 2007 Feb;3(2):117-25
pubmed: 17206139
Methods Mol Med. 2007;137:245-60
pubmed: 18085234
Gene. 2008 Feb 15;409(1-2):100-8
pubmed: 18178340
Cell Motil Cytoskeleton. 2008 Jun;65(6):476-86
pubmed: 18435451
Mol Cancer Ther. 2008 Jul;7(7):2070-9
pubmed: 18645017
Cancer Res. 2008 Nov 1;68(21):8881-8
pubmed: 18974132
J Cell Physiol. 2009 Dec;221(3):505-13
pubmed: 19650075
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Nat Rev Cancer. 2010 Mar;10(3):194-204
pubmed: 20147901
Cancer Res. 2010 Jun 15;70(12):4995-5003
pubmed: 20501838
Eur J Med Chem. 2011 May;46(5):1630-7
pubmed: 21396747
ACS Chem Biol. 2011 Aug 19;6(8):789-99
pubmed: 21539341
PLoS One. 2011;6(6):e21717
pubmed: 21738778
J Mol Biol. 2011 Sep 9;412(1):35-42
pubmed: 21787788
Biochemistry. 2012 Jan 10;51(1):329-41
pubmed: 22148836
Chem Biol. 2012 Jun 22;19(6):686-98
pubmed: 22726683
Science. 2013 Feb 1;339(6119):587-90
pubmed: 23287720
J Cell Biol. 2013 Feb 4;200(3):259-70
pubmed: 23358242
J Clin Oncol. 1990 Jul;8(7):1207-16
pubmed: 2358837
Cancer Lett. 2013 Dec 1;341(2):214-23
pubmed: 23941826
Cancer Res. 2013 Nov 15;73(22):6780-92
pubmed: 24048820
Angew Chem Int Ed Engl. 2014 Feb 3;53(6):1621-5
pubmed: 24470331
J Mol Biol. 2014 Apr 17;426(8):1848-60
pubmed: 24530796
Bioorg Med Chem. 2014 Sep 15;22(18):5078-90
pubmed: 25047938
Bioorg Med Chem Lett. 2014 Dec 1;24(23):5357-63
pubmed: 25455482
PLoS One. 2015 Jun 08;10(6):e0129168
pubmed: 26052950
BMC Cancer. 2015 Jul 23;15:536
pubmed: 26198101
Invest New Drugs. 2016 Feb;34(1):129-37
pubmed: 26686345
Nat Commun. 2016 Jun 30;7:12103
pubmed: 27357539
J Mol Biol. 2016 Jul 31;428(15):2981-8
pubmed: 27395016
Nature. 2016 Nov 24;539(7630):579-582
pubmed: 27775717
J Mol Biol. 2017 Mar 10;429(5):633-646
pubmed: 28104363
Chembiochem. 2017 May 18;18(10):905-909
pubmed: 28207984
Int J Mol Sci. 2017 May 03;18(5):null
pubmed: 28467385
Cell Chem Biol. 2017 Jun 22;24(6):737-750.e6
pubmed: 28579361
Nat Commun. 2017 Jun 06;8:15787
pubmed: 28585532
Eur J Med Chem. 2017 Sep 8;137:488-503
pubmed: 28624703
J Nat Prod. 2018 Mar 23;81(3):494-505
pubmed: 29023132
Lancet Oncol. 2018 Jan;19(1):76-86
pubmed: 29248236
Hum Pathol. 2018 Apr;74:92-98
pubmed: 29339176
ACS Omega. 2016 Dec 31;1(6):1192-1204
pubmed: 30023505
N Engl J Med. 2018 Nov 29;379(22):2108-2121
pubmed: 30345906
Lancet. 1995 Jul 1;346(8966):26-8
pubmed: 7603142
Biochemistry. 1993 Mar 23;32(11):2747-55
pubmed: 8096151
Biochemistry. 1993 Sep 28;32(38):10067-77
pubmed: 8104479
Nature. 1998 Jan 8;391(6663):199-203
pubmed: 9428769
Cell. 1999 Jan 8;96(1):79-88
pubmed: 9989499